Somatic mutations of Zbtb18 have been identified in diseases associated with excessive activity of PI3K, including several human cancers including glioblastoma, ovary, gut, and acute lymphoblastic leukemia patients (44–57). Here, PIK3CG is linked to acute lymphoblastic leukemia.